EVFRAXY solution for injection in pre-filled syringe 60mg/mL
Product details
Registration number: SIN17564P
Classification: Prescription Only
Active ingredients: Denosumab
Strength: 60mg/mL
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: CEDAR PHARMACEUTICALS PTE. LTD.
ATC code: M05BX04
HSA approval date: 23 June 2026
Manufacturer(s): Biocon Biologics Limited
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for EVFRAXY solution for injection in pre-filled syringe 60mg/mL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17564P
Classification: Prescription Only
What active ingredients and strength are recorded for EVFRAXY solution for injection in pre-filled syringe 60mg/mL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Denosumab
Strength: 60mg/mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for EVFRAXY solution for injection in pre-filled syringe 60mg/mL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for EVFRAXY solution for injection in pre-filled syringe 60mg/mL?
According to the HSA dataset updated 7 August 2026:
Registrant: CEDAR PHARMACEUTICALS PTE. LTD.
Which manufacturers and countries are listed for EVFRAXY solution for injection in pre-filled syringe 60mg/mL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Biocon Biologics Limited
Manufacturing country/countries: INDIA
Where can I look up EVFRAXY solution for injection in pre-filled syringe 60mg/mL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17564P or the exact product name EVFRAXY solution for injection in pre-filled syringe 60mg/mL. The general register link does not preselect this product.
What are the source dates for this EVFRAXY solution for injection in pre-filled syringe 60mg/mL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this EVFRAXY solution for injection in pre-filled syringe 60mg/mL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17564P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)